|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
232,105 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,471,016 |
|
|
Indirect Value
|
$4,283,565 |
|
|
Total
Shares |
3,393,580 |
|
|
Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
Director |
|
2015-08-17 |
4 |
AS |
$208.11 |
$353,844 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-09-14 |
4 |
AS |
$202.94 |
$346,605 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-09-14 |
4 |
OE |
$44.51 |
$94,357 |
D/D |
1,700 |
15,476 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-10-07 |
4 |
OE |
$44.51 |
$75,667 |
D/D |
1,700 |
16,076 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-10-07 |
4 |
AS |
$145.12 |
$247,878 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-11-10 |
4 |
AS |
$153.30 |
$261,846 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-11-10 |
4 |
OE |
$44.51 |
$75,667 |
D/D |
1,700 |
16,076 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-12-10 |
4 |
OE |
$44.51 |
$75,667 |
D/D |
1,700 |
16,076 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-12-10 |
4 |
AS |
$178.59 |
$310,037 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-01-04 |
4 |
AS |
$180.65 |
$310,756 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-01-04 |
4 |
OE |
$44.51 |
$75,667 |
D/D |
1,700 |
16,076 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-02-17 |
4 |
AS |
$153.33 |
$263,051 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-02-17 |
4 |
OE |
$44.51 |
$75,667 |
D/D |
1,700 |
16,076 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2010-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,703 |
2,137 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2008-03-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,790 |
44,579 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2008-03-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,790 |
6,263 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
3,937 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-09-01 |
4 |
AS |
$20.04 |
$36,112 |
I/I |
(1,802) |
65,062 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2010-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,865 |
1,937 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,910 |
14,376 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-12-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
10,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-12-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-08-05 |
4 |
AS |
$20.01 |
$40,020 |
I/I |
(2,000) |
4,481 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-09-08 |
4 |
AS |
$31.75 |
$63,500 |
I/I |
(2,000) |
2,481 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-10-07 |
4 |
AS |
$34.75 |
$69,500 |
I/I |
(2,000) |
481 |
|
- |
|
424 Records found
|
|
Page 5 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|